Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
24.34
-0.44 (-1.78%)
Mar 31, 2025, 9:39 AM EDT - Market open
Fresenius Medical Care AG Revenue
In the year 2024, Fresenius Medical Care AG had annual revenue of 19.34B EUR, down -0.61%. Fresenius Medical Care AG had revenue of 5.08B in the quarter ending December 31, 2024, with 1.94% growth.
Revenue (ttm)
19.34B EUR
Revenue Growth
-0.61%
P/S Ratio
0.73
Revenue / Employee
173,396 EUR
Employees
111,513
Market Cap
14.60B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 19.34B | -117.71M | -0.61% |
Dec 31, 2023 | 19.45B | 55.60M | 0.29% |
Dec 31, 2022 | 19.40B | 1.78B | 10.10% |
Dec 31, 2021 | 17.62B | -240.38M | -1.35% |
Dec 31, 2020 | 17.86B | 382.51M | 2.19% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
FMS News
- 18 days ago - Fresenius Medical Care publishes its joint Annual Report and Sustainability Statement for 2024: Building the Momentum - PRNewsWire
- 27 days ago - Fresenius Medical Care's stock falls on Fresenius' stake sale - Reuters
- 4 weeks ago - Fresenius Medical Care AG (FMS) Q4 2024 Earnings Conference Call Transcript - Seeking Alpha
- 4 weeks ago - Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025 - PRNewsWire
- 4 weeks ago - Fresenius Medical Care slightly beats market estimates in fourth quarter - Reuters
- 5 weeks ago - Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics - PRNewsWire
- 2 months ago - Fresenius Medical Care: A 'Buy' Going Into 2025 - Seeking Alpha
- 3 months ago - Fresenius Medical Care Listed in The Dow Jones Sustainability World Index and for the 15th Time in The Dow Jones Sustainability Europe Index - PRNewsWire